Experimental hepatitis B drug may offer 'functional cure' for some patients

Experimental hepatitis B drug may offer 'functional cure' for some patients

A first-of-its-kind drug for hepatitis B is letting some patients stop treatment without showing signs of the dangerous liver virus, what's called a "functional cure," researchers reported Thursday.

Original Source

Read the full article at Washingtontimes →

KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.